title: Authors' reply to the comment on "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial" by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226-32].
authors.affiliation: Chongqing Medical Nutrition Research Center, Chongqing Key Laboratory of Nutrition and Food Safety, Research Center for Nutrition and Food Safety, Institute of Military Preventive Medicine, Third Military Medical University, Chongqing, China.
authors.forename: Jun-Dong
authors.initials: JD
authors.lastname: Zhu
authors.affiliation: Chongqing Medical Nutrition Research Center, Chongqing Key Laboratory of Nutrition and Food Safety, Research Center for Nutrition and Food Safety, Institute of Military Preventive Medicine, Third Military Medical University, Chongqing, China.
authors.forename: Qian-Yong
authors.initials: QY
authors.lastname: Zhang
authors.affiliation: Chongqing Medical Nutrition Research Center, Chongqing Key Laboratory of Nutrition and Food Safety, Research Center for Nutrition and Food Safety, Institute of Military Preventive Medicine, Third Military Medical University, Chongqing, China. Electronic address: mimantian@hotmail.com.
authors.forename: Man-Tian
authors.initials: MT
authors.lastname: Mi
mesh_terms: D001786:Blood Glucose / Q000187:drug effects*; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D050356:Lipid Metabolism / Q000187:drug effects*; D008297:Male; D065626:Non-alcoholic Fatty Liver Disease / Q000188:drug therapy*; D013267:Stilbenes / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D013267:Stilbenes